Guyana cancels Frontera-CGX Energy's prospecting license-March 2024-www.financetom.com

Guyana cancels Frontera-CGX Energy's prospecting license

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Guyana cancels Frontera-CGX Energy's prospecting license

Mar 13, 2025 7:22 AM

March 13 (Reuters) - Guyana's government has cancelled

the Frontera and CGX Energy ( CGXEF ) joint venture's

prospecting license for the Corentyne block, the companies said

on Thursday.

In February, the South American nation gave a 30-day notice

to CGX and Frontera for cancellation of the license.

Previous page： Champion Iron Reports Q4 Production and Mining Operation Expenditures Next page： Thermo Fisher's Fiscal Q1 Adjusted Earnings Rise While Revenue Falls; Fiscal 2024 Outlook Updated -- Shares Advance Pre-Bell

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Champion Iron Reports Q4 Production and Mining Operation Expenditures

Apr 24, 2024

06:47 AM EDT, 04/24/2024 (MT Newswires) -- Champion Iron ( CIAFF ) overnight Tuesday reported production results and mining operation expenditures for its financial fourth quarter ended March 31. Detailed operational and audited financial results are to be released prior to the company's conference call and webcast scheduled for May 31. Among highlights from the Q4 update, the company cited...

Thermo Fisher's Fiscal Q1 Adjusted Earnings Rise While Revenue Falls; Fiscal 2024 Outlook Updated -- Shares Advance Pre-Bell

Apr 24, 2024

06:46 AM EDT, 04/24/2024 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) reported fiscal Q1 adjusted earnings Wednesday of $5.11 per diluted share, up from $5.03 a year earlier. Analysts polled by Capital IQ expected $4.71. Revenue for the quarter ended March 30 was $10.34 billion, down from $10.71 billion a year earlier. Analysts surveyed by Capital IQ expected...

Biogen beats quarterly profit estimates, Alzheimer's drug sales jump

Apr 24, 2024

April 24 (Reuters) - Biogen beat Wall Street estimates for first-quarter profit on Wednesday, helped by a series of cost-cutting measures as older drugs face fierce competition. The company also said its Alzheimer's drug Leqembi, developed with Japanese partner Eisai ( ESALF ), recorded global sales of about $19 million, nearly tripling from the fourth quarter of 2023. The number...

Liftmaker Otis beats first-quarter profit estimates on high demand for maintenance

Apr 24, 2024

April 24 (Reuters) - Elevator and escalator maker Otis Worldwide Corp ( OTIS ) beat quarterly profit estimates on Wednesday on higher demand for maintenance and repair services on its elevators. The Farmington Connecticut-based company operates globally through two segments - new equipment which manufactures and installs passenger and freight elevators, escalators and moving walkways, and service segment which offers...